Canopy Growth Corporation (NASDAQ:CGC) Q3 2024 Earnings Conference Call February 9, 2024 10:00 AM ET Company Participants Sarah Pare - VP of IR David Klein - CEO Judy Hong - CFO Conference Call Participants Michael Lavery - Piper Sandler Tamy Chen - BMO Capital Markets Aaron Grey - Alliance Global Partners John Zamparo - CIBC Bill Kirk - Roth MKM Matt Bottomley - Canaccord Genuity Operator Good morning. My name is Joanna, and I will be your conference operator today. I would like to welcome you to Canopy Gr ...

Canopy Growth Corp. CGC, -4.86% WEED, -4.79% said Friday it plans to seek approval from shareholders for a plan to close its acquisitions of cannabis-touching, U.S.-based businesses under the Canopy USA name. The Canadian cannabis company said it expects to file a definitive proxy with the SEC for Canopy USA on or about Feb. 13 for an April 12 shareholder vote on the structure. “Canopy USA is advancing and following our shareholder vote will be able to move forward with completing its acquisitions of Jetty ...

Canada adult-use cannabis business-to-business net revenue up 9% year-over-year; Canada medical cannabis net revenue up 11% year-over-year Focused execution drove sustained margin improvement with second quarter of consolidated gross margins exceeding 30% Canopy USA strategy moving forward; special shareholder meeting scheduled for April 12, 2024 SMITHS FALLS, ON, Feb. 9, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC) today announces its financial ...

Other • Decrease in expense of $3.6 million related to non-cash fair value changes on our debt, from $9.0 million in the third quarter of fiscal 2023 to $5.4 million in the third quarter of fiscal 2024. The year-over-year change is driven by the fair value change of the unsecured senior notes in the third quarter of fiscal 2023 versus the fair value changes on the CBI Note in the third quarter of fiscal 2024. | --- | --- | --- | --- | --- | --- | --- | --- | |------------------------------------------------ ...

Canadian Cannabis Companies to Eye in February 2024As we navigate through 2024, the Canadian cannabis sector and top marijuana stocks remain a hotbed of investment opportunities. With Canada at the forefront of cannabis legalization, several companies have emerged as key players. Overall, these firms range from large-scale producers to niche market innovators. Investors are keenly watching these stocks. This week, particular attention is on those demonstrating strong financial health, strategic partnerships ...

Canopy Growth Corporation (CGC) closed at $4.79 in the latest trading session, marking a -0.83% move from the prior day. The stock's performance was behind the S&P 500's daily loss of 0.06%. Elsewhere, the Dow saw an upswing of 0.35%, while the tech-heavy Nasdaq depreciated by 0.76%.Coming into today, shares of the company had lost 5.48% in the past month. In that same time, the Medical sector gained 1.65%, while the S&P 500 gained 3.36%.The investment community will be closely monitoring the performance of ...

SMITHS FALLS, ON, Jan. 26, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) will release its financial results for the third quarter fiscal year 2024 ended December 31, 2023 before financial markets open on February 9, 2024. Following the release of its third quarter fiscal year 2024 financial results, Canopy Growth will host an audio webcast with David Klein, CEO and Judy Hong, CFO on February 9, at 10AM Eastern Time. Webcast Information A live au ...

SMITHS FALLS, ON, Jan. 24, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC), a world-leading diversified cannabis company, today announced the introduction of new product offerings across the Company's adult use and medical cannabis portfolio, including new Tweed softgels and oils featuring minor cannabinoids, a large format flower offering from Tweed, as well as new medical exclusive pre-roll products from 7ACRES and Spectrum Therapeutics. "In addit ...

Will Federal Reform Lead To Bounce For Marijuana Stocks?With almost the first month of 2024 gone legal cannabis is put on the front lines once again. Over the next several months we will see more states try to not only pass legalization measures but improve upon existing laws. Although cannabis is still federally illegal more than half of the US has legalized cannabis in some form. Whether it is a recreational market or a medical market being able to operate legally is a major win. Yet it is only one of the ...

In the latest market close, Canopy Growth Corporation (CGC) reached $4.41, with a +0.92% movement compared to the previous day. The stock's performance was ahead of the S&P 500's daily gain of 0.22%. On the other hand, the Dow registered a gain of 0.36%, and the technology-centric Nasdaq increased by 0.32%.Coming into today, shares of the company had lost 14.98% in the past month. In that same time, the Medical sector gained 2.3%, while the S&P 500 gained 1.61%.Analysts and investors alike will be keeping a ...